Latest Insider Transactions at Arcutis Biotherapeutics, Inc. (ARQT)
This section provides a real-time view of insider transactions for Arcutis Biotherapeutics, Inc. (ARQT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcutis Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcutis Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 01
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-1.16%
|
$270,000
$27.5 P/Share
|
May 21
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,612
+0.38%
|
$1,612
$1.13 P/Share
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
96,574
-100.0%
|
-
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
96,574
+50.0%
|
-
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
2,108,558
-20.0%
|
-
|
May 07
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
750
-0.13%
|
$26,250
$35.0 P/Share
|
May 07
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+0.13%
|
$750
$1.68 P/Share
|
May 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$59,500
$34.0 P/Share
|
May 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,607
+0.27%
|
$1,607
$1.68 P/Share
|
May 03
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.52%
|
$74,800
$34.84 P/Share
|
May 03
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.34%
|
$6,600
$3.29 P/Share
|
Apr 30
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,500
-0.25%
|
$52,500
$35.0 P/Share
|
Apr 20
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$280,000
$28.26 P/Share
|
Apr 16
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,655
+0.42%
|
$2,655
$1.31 P/Share
|
Apr 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$50,750
$29.93 P/Share
|
Apr 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.52%
|
$63,800
$29.5 P/Share
|
Apr 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.35%
|
$6,600
$3.29 P/Share
|
Mar 22
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$310,000
$31.1 P/Share
|
Mar 16
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,653
+0.42%
|
$2,653
$1.31 P/Share
|
Mar 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,250
-1.42%
|
$40,000
$32.9 P/Share
|
Mar 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.07%
|
$16,000
$32.9 P/Share
|
Mar 10
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.06%
|
$500
$1.68 P/Share
|
Mar 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$52,500
$30.55 P/Share
|
Mar 04
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,396
+21.11%
|
$12,396
$1.68 P/Share
|
Mar 03
2021
|
Patricia A. Turney SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+33.6%
|
-
|
Mar 03
2021
|
David W Osborne Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+3.71%
|
-
|
Mar 03
2021
|
Kenneth A. Lock Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+23.08%
|
-
|
Mar 03
2021
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+50.0%
|
-
|
Mar 03
2021
|
John W Smither Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+21.88%
|
-
|
Mar 03
2021
|
Todd Franklin Watanabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+5.18%
|
-
|
Mar 02
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,107
-0.37%
|
$73,745
$35.19 P/Share
|
Mar 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.53%
|
$74,800
$34.61 P/Share
|
Mar 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.35%
|
$6,600
$3.29 P/Share
|
Mar 01
2021
|
Kenneth A. Lock Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
933
-4.04%
|
$31,722
$34.2 P/Share
|
Mar 01
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
773
-3.07%
|
$26,282
$34.2 P/Share
|
Mar 01
2021
|
Patricia A. Turney SVP, Operations |
SELL
Open market or private sale
|
Direct |
934
-9.15%
|
$31,756
$34.52 P/Share
|
Mar 01
2021
|
David W Osborne Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
780
-0.33%
|
$26,520
$34.57 P/Share
|
Feb 22
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.56%
|
$350,000
$35.66 P/Share
|
Feb 16
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,654
+0.43%
|
$2,654
$1.31 P/Share
|
Feb 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
2,000
-2.22%
|
$70,000
$35.64 P/Share
|
Feb 10
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
750
-2.89%
|
$26,250
$35.64 P/Share
|
Feb 10
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+2.81%
|
$750
$1.68 P/Share
|
Feb 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.87%
|
$340,000
$34.13 P/Share
|
Feb 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.7%
|
$10,000
$1.68 P/Share
|
Feb 04
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,861
+4.58%
|
$19,861
$1.68 P/Share
|
Feb 01
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
3,750
-4.0%
|
$131,250
$35.0 P/Share
|
Feb 01
2021
|
John W Smither Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,250
-4.73%
|
$43,750
$35.0 P/Share
|
Feb 01
2021
|
John W Smither Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+4.51%
|
$1,250
$1.68 P/Share
|
Feb 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.3%
|
$74,800
$34.74 P/Share
|
Feb 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.59%
|
$2,200
$1.68 P/Share
|